Appointment of Medical Division CEO
Stuart Gall appointed Divisional CEO of Medical Imaging division, effective on or before 10 March 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your AVG notes
Avingtrans Plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce the appointment of Stuart Gall as Divisional Chief Executive Officer of its medical imaging businesses division, including Adaptix Ltd and Magnetica Ltd, with effect from on or before 10 March 2026.
Stuart was previously Chief Executive Officer of Intelligent Ultrasound Group plc, a medical technology company focused on ultrasound simulation and artificial intelligence-based image analysis. He has significant experience in the development and commercialisation of novel medical imaging technologies and in leading companies from spin-out stage to public markets.
Steve McQuillan, CEO of Avingtrans, commented: "We are pleased to welcome Stuart to Avingtrans and look forward to him joining the business formally. His experience and leadership in scaling medical imaging technologies will support the continued development of Adaptix and Magnetica as they move towards commercialisation."
Business units
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.